Tilray Inc (NASDAQ:TLRY - Get Free Report)'s share price traded down 5.2% during mid-day trading on Thursday . The company traded as low as $0.68 and last traded at $0.68. 8,478,878 shares traded hands during mid-day trading, a decline of 81% from the average session volume of 45,182,949 shares. The stock had previously closed at $0.72.
Analyst Upgrades and Downgrades
Separately, Canaccord Genuity Group raised their price target on shares of Tilray from $2.00 to $3.00 and gave the stock a "buy" rating in a research report on Monday, January 13th. Three equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of "Hold" and an average price target of $2.70.
Check Out Our Latest Research Report on Tilray
Tilray Trading Up 2.6 %
The stock has a market capitalization of $650.45 million, a P/E ratio of -2.31 and a beta of 2.13. The company has a current ratio of 2.54, a quick ratio of 1.58 and a debt-to-equity ratio of 0.10. The business has a 50-day moving average price of $1.05 and a two-hundred day moving average price of $1.38.
Tilray (NASDAQ:TLRY - Get Free Report) last posted its quarterly earnings data on Friday, January 10th. The company reported ($0.10) earnings per share for the quarter, missing the consensus estimate of ($0.03) by ($0.07). Tilray had a negative return on equity of 4.40% and a negative net margin of 30.95%. The firm had revenue of $210.90 million for the quarter, compared to the consensus estimate of $216.34 million. The firm's revenue for the quarter was up 8.7% compared to the same quarter last year. On average, analysts expect that Tilray Inc will post -0.2 EPS for the current fiscal year.
Institutional Inflows and Outflows
A number of hedge funds have recently added to or reduced their stakes in the company. Ferguson Wellman Capital Management Inc. acquired a new stake in shares of Tilray in the 3rd quarter valued at $26,000. Lido Advisors LLC acquired a new position in Tilray during the fourth quarter worth about $28,000. Verdence Capital Advisors LLC bought a new position in shares of Tilray in the fourth quarter worth about $29,000. Dudley Capital Management LLC acquired a new stake in shares of Tilray in the 4th quarter valued at approximately $29,000. Finally, Ameritas Advisory Services LLC bought a new stake in shares of Tilray during the 4th quarter valued at approximately $32,000. 9.35% of the stock is owned by institutional investors.
Tilray Company Profile
(
Get Free Report)
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.
See Also
Before you consider Tilray, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tilray wasn't on the list.
While Tilray currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
